Bias in published cost effectiveness studies: systematic review

CM Bell, DR Urbach, JG Ray, A Bayoumi, AB Rosen… - Bmj, 2006 - bmj.com
Objective To investigate if published studies tend to report favourable cost effectiveness
ratios (below 20000, 50 000, and 100000perqualityadjustedlifeyear(QALY)gained)andevaluatestudycharacteristicsassociated …

[图书][B] Redefining health care: creating value-based competition on results

ME Porter, EO Teisberg - 2006 - books.google.com
The US health care system is in crisis. At stake are the quality of care for millions of
Americans and the financial well-being of individuals and employers squeezed by …

Developing drugs for developing countries

DB Ridley, HG Grabowski, JL Moe - Health Affairs, 2006 - healthaffairs.org
Infectious and parasitic diseases create enormous health burdens, but because most of the
people suffering from these diseases are poor, little is invested in developing treatments. We …

Do oncologists believe new cancer drugs offer good value?

E Nadler, B Eckert, PJ Neumann - The oncologist, 2006 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Describe how
academic oncologists view the costs of new treatments in their treatment recommendations …

Cost-effectiveness of neonatal ECG screening for the long QT syndrome

S Quaglini, C Rognoni, C Spazzolini… - European heart …, 2006 - academic.oup.com
Aims A significant number of preventable cardiac deaths in infancy and childhood are due to
long QT syndrome (LQTS) and to unrecognized neonatal congenital heart diseases (CHDs) …

Association of industry sponsorship to published outcomes in gastrointestinal clinical research

A Brown, D Kraft, SM Schmitz, V Sharpless… - Clinical …, 2006 - Elsevier
Background & Aims: Recent years have seen an increase in industry sponsorship of clinical
trials throughout medicine. We conducted a study to evaluate the association of industry …

Surplus appropriation from R&D and health care technology assessment procedures

T Philipson, A Jena - 2006 - nber.org
Given the rapid growth in health care spending that is often attributed to technological
change, many private and public institutions are grappling with how to best assess and …

The costs and benefits of front-loading and predictability of immunization

OM Barder, E Yeh - Center for Global Development Working Paper, 2006 - papers.ssrn.com
How can the international community save more children's lives faster and more effectively
in the 21st century? This working paper analyzes the extent to which" frontloading" and …

Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers: What can we learn from clinical research?

HG Eichler, SX Kong, JP Grégoire - The European Journal of Health …, 2006 - Springer
Research collaborations between academic researchers, regulatory agencies, and
pharmaceutical manufacturers have made the drug development process more efficient and …

Intellectual property and health in developing countries

J Tirole - Understanding poverty, 2006 - books.google.com
Few issues are as controversial as the impact of intellectual property on health in developing
countries. Activists and poor countries' governments have, for example, long claimed that …